Stockreport

Morgan Stanley Favors GoodRx (GDRX) and Healthcare Tech Over Managed Care for 2026 Citing Strong Market-Beating Potential [Yahoo! Finance]

GoodRx Holdings, Inc. - Class A  (GDRX) 
PDF on GoodRx to $4 from $5 and kept an Equal Weight rating on the shares. In a 2026 outlook for the Healthcare Services sector, the firm highlighted a strong environment fo [Read more]